Behaviorally augmented tolerance during chronic cholinesterase reduction by paraoxon

Area of Science:

• Neuroscience
• Pharmacology
• Behavioral Science

Background:

• Organophosphates, like paraoxon, are known neurotoxins that inhibit acetylcholinesterase.
• Repeated exposure to organophosphates can lead to tolerance, but the mechanisms are not fully understood.
• Previous research suggests potential involvement of metabolic, physiological, and behavioral factors in tolerance development.

Purpose of the Study:

• To investigate the development of tolerance to paraoxon in a rat avoidance learning paradigm.
• To determine if tolerance to paraoxon involves a learned behavioral component.
• To assess whether organophosphate tolerance is associated with an 'antimuscarinic-like' syndrome.

Main Methods:

• Rats received daily subcutaneous injections of paraoxon (0.125 mg/kg) 2 hours before avoidance sessions.
• Control groups received paraoxon at different timings or were not tested to isolate treatment effects.
• Tolerance was assessed by performance changes in avoidance tasks, and an active-passive avoidance task was used to evaluate antimuscarinic sensitivity.

Main Results:

• Daily paraoxon administration induced performance depression followed by progressive tolerance.
• Tolerance development was not solely due to metabolic/physiological changes, indicating a significant behavioral component.
• Rats tolerant to paraoxon did not exhibit enhanced sensitivity to antimuscarinics in an avoidance task.

Conclusions:

• Chronic paraoxon tolerance involves a learned, behaviorally augmented component.
• The development of tolerance to organophosphates does not appear to be linked to a spontaneous 'antimuscarinic-like' syndrome.
• These findings highlight the complex interplay of physiological and behavioral mechanisms in neurotoxin tolerance.